The fear of contracting HIV has run my life for what feels like forever, and I’m not willing to let it control me any longer.
23 August 2016 | The Advocate
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for once-daily Truvada® (emtricitabine 200 mg/tenofovir disoproxil 245 mg; FTC/TDF) in combination with safer-sex practices to reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk, a strategy known as pre-exposure prophylaxis, or PrEP.
22 August 2016 | Gilead press release
PrEPster, along with NAT and THT, and other organisations in the United4PrEP coalition is urging individuals and institutions to take part in the NHS England PrEP consultation. The results from the consultation will be considered by the NHS England committee (CPAG) that makes the final decision on PrEP. Together, we’ve produced toolkits that assist individuals and organisations in responding to the consultation, along with sample responses.
22 August 2016 | Prepster
Truvada, an expensive breakthrough drug that prevents people from getting HIV won't be funded by taxpayers in Australia this year, the nation's drug funding panel has ruled. A Department of Health spokeswoman said the PBAC understood "this is an important new prevention medication for HIV", but decided the price set by the drug's sponsor, Gilead Sciences, was too high and a proposal to limit subsidy to a small subset of the "at risk" group was not feasible.
"In its deliberations the PBAC indicated a substantial price reduction would be needed to make Truvada available for PrEP for the whole 'at risk' population, but noted that Truvada for PrEP could represent value for money in the broader population at a substantially lower price," the spokeswoman said.
19 August 2016 | Sydney Morning Herald
Londoners are being urged to share their views and opinions on PrEP with NHS England. Councillor Teresa O’Neill OBE, London Councils’ Executive member for health, stressed the importance of Londoners sharing their views as a large portion of those living with HIV reside in the capital. “We are concerned that NHS England, by arguing it is not responsible for funding PrEP, is trying to shift costs to local authorities."
16 August 2016 | Gay Times
Recent studies show an increase in unprotected sex amongst HIV-negative gay men. Why are some of us ditching condoms? And in a world of treatment, undetectability and PrEP, is this the start of generation bareback?
15 August 2016 | FS
If we can fund the contraceptive pill, we can fund PrEP. Funding for drugs should only ever be based on clinical evaluation, cost effectiveness and the impact on society more widely. Each one of those criteria have been met in my mind, and for this reason NHS England should move in the direction of funding PrEP.
15 August 2016 | Conservative Home
In March 2015, Simon Stevens, Chief Executive of NHS England, announced the first national diabetes prevention programme. Reflecting on the potential for the NHS to reduce the future costs of diabetes care by supporting people to lose weight, exercise and eat better, he said that "if these results were from a pill we'd doubtless be popping it".
11 August 2016 | National AIDS Trust
If the NHS ever comes to be dismantled it won’t be because a heartless Tory government has decided that, for reasons of neoliberal ideology, it ought to be replaced by private insurance schemes. It will be because the unreasonable and limitless demands placed on it by those who claim to be its friends have inflated its budget to a level that public funds can simply no longer sustain.
11 August 2016 | The Spectator
NHS England has said it “strongly denies” the accusations of homophobia levelled at it last week following its statement regarding the drug that prevents HIV – but refused to comment further.
09 August 2016 | BuzzFeed News